Ensemble Discovery Corp.
This article was originally published in Start Up
Executive Summary
Ensemble Discovery Corp. is developing a breakthrough system for assembling and discovering new molecular entities. The company's proprietary technology, DNA-Programmed Chemistry, can quickly synthesize molecules that are intractable to traditional synthesis techniques as well as identify and purify novel molecules with desired properties.
You may also be interested in...
The A-List: 2004's Trend-Shaping Series A Financings
Analyzing the venture financings closed by 2004's new crop of biotech, diagnostics, and medical device start-ups reveals today's trends that may shape tomorrow's health care industry. Here we point out eleven 2004 Series A financings that identify and illustrate what's hot.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.